Exponent (EXPO) Set to Announce Earnings on Thursday

Key Points

• Exponent is expected to report Q3 2026 earnings after market close on October 29. Analysts forecast earnings of $0.596 per share on revenue of $149.48 million; the conference call is scheduled for 4:30 p.m. ET.
• The company’s previous quarter exceeded expectations, with EPS of $0.60 versus $0.55 expected and revenue of $171.61 million, up 12% year over year.
• Analyst sentiment is moderately bullish, with a consensus price target of $81 and a “Moderate Buy” rating. Exponent also pays a $0.31 quarterly dividend, equivalent to a 1.7% yield.

Exponent (NASDAQ:EXPO - Get Free Report) is projected to release its Q3 2026 results after the market closes on Thursday, October 29th. Analysts expect Exponent to post earnings of $0.5960 per share and revenue of $149.48 million for the quarter. Parties can find conference call details on the company's upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Thursday, October 29, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%. The firm had revenue of $171.61 million during the quarter, compared to the consensus estimate of $144.99 million. During the same period in the prior year, the company earned $0.52 EPS. The company's quarterly revenue was up 12.0% compared to the same quarter last year. On average, analysts expect Exponent to post $2.31 EPS for the current fiscal year and $2.67 EPS for the next fiscal year.

Exponent Stock Performance

EXPO stock opened at $73.15 on Thursday. The firm has a fifty day moving average price of $68.84 and a 200 day moving average price of $64.38. Exponent has a fifty-two week low of $51.91 and a fifty-two week high of $81.95. The firm has a market cap of $3.48 billion, a PE ratio of 32.80 and a beta of 0.69.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, September 18th. Investors of record on Friday, September 4th were paid a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, September 4th. This represents a $1.24 dividend on an annualized basis and a yield of 1.7%. Exponent's dividend payout ratio is presently 55.61%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. JPMorgan Chase & Co. increased their price objective on shares of Exponent from $80.00 to $90.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. UBS Group set a $72.00 price objective on shares of Exponent and gave the stock a "neutral" rating in a research note on Friday, July 31st. Finally, Weiss Ratings upgraded shares of Exponent from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, October 9th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $81.00.

Insider Transactions at Exponent

In other news, CEO Catherine Corrigan sold 1,707 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $66.28, for a total value of $113,139.96. Following the completion of the sale, the chief executive officer directly owned 129,108 shares of the company's stock, valued at $8,557,278.24. This trade represents a 1.30% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is currently owned by company insiders.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.